Strand Life Sciences Strand Life Sciences Strand Life Sciences Strand Life Sciences Strand Life Sciences

Genes run in the family. So could cancer risk.
The way to find out is by genomic testing

General Population

12%

BRCA1 gene defect

55-65%

BRCA2 gene defect

45%

Inherited cancer risk

About 12% of women in the general population will develop breast cancer sometime during their lives.

By contrast, 55 – 65% of women who inherit a harmful BRCA1 mutation will develop breast cancer by age 70 years.

Similarly, for women who inherit a harmful BRCA2 mutation, the chances are 45%.

Who should be tested?

Are there multiple members in the family who have had cancer?

Are there any family members who have had cancer at an early age?

These are some signs that family members could be at risk and may need testing.

About the test

The Strand® Hereditary Cancer Test evaluates a number of genes associated with cancer risk.

Some of the cancers tested are Breast, Ovarian, Prostate, Colon, Pancreatic and other rarer cancers.

What does the test outcome mean?

The outcome of the test is usually an overall positive or negative cancer risk.

A negative result usually means the person is not at increased risk for developing cancer.

A positive result indicates increased risk for developing cancer.

This information helps you take charge and manage your health much better.

How to order the Strand Hereditary Cancer Test?

It is good to be informed about genomic testing for cancer. However, the need for testing should be determined by an oncologist.

Step by step procedure for saliva sample collection.